newsfilter
← Latest News
GlobeNewswire·

NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results

Prioritize and focus resources on LNCB74 (B7-H4 ADC) with a planned IND submission by year-endCash of approximately $75 million expected to fund operations into second half of 2026 BELTSVILLE, Md., Nov. 07, 2024